Newsletter | August 1, 2026
TECH FRICTION AND TRIAL DESIGN
Why Clinical Trial Sites Are Drowning In Tech Chaos
By John Oncea, Clinical Tech Leader
Sites are not rejecting tech; they are overwhelmed by disconnected systems, slow documents, and sponsor-driven manual workarounds.
Who Decides The Clinical Trial Tech Stack?
Integration works best when validation, economics, and site diversity are considered before the stack is locked in.
The Risks And Unresolved Rules Of Real-Time Clinical Trials
Real-time clinical trials raise hard questions around liability, blinding, DSMB overlap, and AI accountability that deserve a closer look.
AI, AUTOMATION, AND GOVERNANCE
How AI Is Reshaping RTSM Study Builds
By E.K. Koh, Suvoda
Agentic RTSM can cut build timelines dramatically while keeping compliance, quality, and auditability intact.
Build Quality At The Source To Cut Data-Cleaning Costs
By CRIO
Reducing downstream cleaning can speed timelines, lower error rates, and create a stronger competitive position.
Who Decides? AI Governance In Clinical Research
By Andrea Bastek, Florence Healthcare
Clear ownership, consistent policy, and aligned teams help clinical research manage AI risk and innovate responsibly.
TOOLS FOR FASTER STUDY STARTUP
Speed Study Startup Through Better Collaboration
Advarra
ICH E6(R3): What To Do Next
Castor
Direct-To-Patient Supply Management For DCTs
Almac Clinical Technologies